OPGN: the cash flow

MyFinsight

For the quarter ending 2025-09-30, OPGN had -$896,442 decrease in cash & cash equivalents over the period.

Cash Flow	2025-09-30
Net cash used in investing activities	0
Effects of exchange rates on cash	0
Change in inventory reserve	0
Loss on deconsolidation of subsidiaries	0
Change in fair value of eib loan guaranty	0
Gain on impairment adjustment	0
Gain on settlement of compensation expenses	0
Inventory	0
Deferred revenue	0
Net income	2,493,129
Depreciation and amortization	141,043
Accounts receivable	4,014,580
Prepaid expenses and other current assets	-244,269
Deferred offering costs	6,269
Intangible assets	50,000
Accounts payable	62,580
Accrued compensation and benefits	-37,463
Accrued liabilities	19,681
Operating lease liabilities	-127,821
Stock compensation expense	284,208
Net cash used in operating activities	-978,685
Proceeds from issuance of preferred stock, net of issuance costs	0
Payments on finance lease obligations	0
Proceeds from short term insurance financing	284,304
Payments on short term insurance financing	202,061
Net cash provided by financing activities	82,243
Net (decrease) increase in cash, cash equivalents and restricted cash	-896,442
Cash and cash equivalents at beginning of period	1,612,915
Cash and cash equivalents at end of period	716,473

Unit: Dollar. Numbers labeled with * are estimated quarterly values.